Evidence map›Paper›PMID 34299558›Full record

ArticleMolecules (Basel, Switzerland)2021

Evaluation of Ruthenium(II)

Hilke Burmeister, Pascal Dietze, Lutz Preu, Julia E Bandow, Ingo Ott

Open access · goldAbstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.3field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 15 citations in OpenAlex.

  1. Biological Activities of Ruthenium NHC Complexes: An Update.Antibiotics (Basel, Switzerland) · 2023
    Review
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Hilke BurmeisterInstitute of Medicinal and Pharmaceutical Chemistry, Technische Universität Braunschweig, Beethovenstr. 55, 38106 Braunschweig, Germany.
Pascal DietzeApplied Microbiology, Faculty of Biology and Biotechnology, Ruhr University Bochum, Universitätsstr. 150, 44801 Bochum, Germany.
Lutz PreuInstitute of Medicinal and Pharmaceutical Chemistry, Technische Universität Braunschweig, Beethovenstr. 55, 38106 Braunschweig, Germany.ORCID 0000-0003-4203-3874
Julia E BandowApplied Microbiology, Faculty of Biology and Biotechnology, Ruhr University Bochum, Universitätsstr. 150, 44801 Bochum, Germany.
Ingo OttInstitute of Medicinal and Pharmaceutical Chemistry, Technische Universität Braunschweig, Beethovenstr. 55, 38106 Braunschweig, Germany.
Technische Universität Braunschweig · DERuhr University Bochum · DE

Funding

European Regional Development Fund CESAR xFederal State of North Rhine-Westphalia xNiedersächsisches Ministerium für Wissenschaft und Kultur x
6 · The paper itself

Abstract

A series of ruthenium(II) complexes with

Indexed as

Anti-Bacterial AgentsBacteriaBacterial InfectionsBacterial ProteinsCoordination ComplexesHeterocyclic CompoundsHumansMethaneModels, MolecularRutheniumThioredoxin-Disulfide ReductaseAnti-Bacterial AgentsBacterial ProteinscarbeneCoordination ComplexesHeterocyclic CompoundsMethaneRutheniumThioredoxin-Disulfide ReductaseantibacterialN-heterocyclic carbenesrutheniumthioredoxin reductase

Identifiers

PMID34299558
PMCPMC8303947
OpenAlexW3180862736

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.